DK0060257814

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetesZealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes

April 24, 2025 01:00 ET  | Source: Zealand Pharma Press release – No. 6 / 2025 Zealand Pharma announces first…

1 week ago
Zealand Pharma launches long-term incentive programs for Zealand Pharmas Board of Directors, Corporate Management and employees for 2025Zealand Pharma launches long-term incentive programs for Zealand Pharmas Board of Directors, Corporate Management and employees for 2025

Zealand Pharma launches long-term incentive programs for Zealand Pharmas Board of Directors, Corporate Management and employees for 2025

April 19, 2025 16:00 ET  | Source: Zealand Pharma Company announcement – No. 9 / 2025 Zealand Pharma launches long-term…

2 weeks ago
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025Total number of shares and voting rights in Zealand Pharma as of March 31, 2025

Total number of shares and voting rights in Zealand Pharma as of March 31, 2025

March 31, 2025 17:00 ET  | Source: Zealand Pharma Company announcement – No. 8 / 2025 Total number of shares…

1 month ago
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated personsTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Company announcement – No. 53 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities…

4 months ago
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.

Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.

Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, 25…

4 months ago
Zealand Pharma to participate in the Jefferies London Healthcare ConferenceZealand Pharma to participate in the Jefferies London Healthcare Conference

Zealand Pharma to participate in the Jefferies London Healthcare Conference

Press Release – No. 11 / 2024 Zealand Pharma to participate in the Jefferies London Healthcare Conference Copenhagen, Denmark, November 13,…

6 months ago